{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:19:54Z","timestamp":1781738394579,"version":"3.54.5"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The diagnostic accuracy of the Gaxilose test (GT) for hypolactasia diagnosis has already been proved. The objectives of this clinical trial were to demonstrate the noninferiority of the GT compared to the hydrogen breath test (HBT) on the impact on diagnostic thinking and patient management, to evaluate the GT reproducibility with urine accumulated from 0 to 4\u200ahours and from 0 to 5\u200ahours and to assess test safety.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a randomized, parallel, noninferiority clinical trial. Patients with clinical symptoms suggestive of lactose intolerance were screened for inclusion and randomly assigned to the GT arm or the HBT arm of the study. The impact on diagnostic thinking and patient management was analyzed with pretest and posttest questionnaires in which the investigators indicated their estimated probability of hypolactasia diagnosis and the intended management before and after the GT or the HBT (noninferiority margin: \u221210%). The primary outcome of the study was the impact on diagnostic thinking, expressed as the mean of the absolute values of the differences between the pretest and posttest probabilities of hypolactasia diagnosis. Patients randomized to the GT arm performed also the retest to evaluate the reproducibility of the GT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 147 patients were included in the intend-to-treat (ITT) population. Among them, 74 performed the HBT and 73 performed the GT. The results proved the noninferiority of the GT compared to the HBT on the impact on diagnostic thinking (Impact<jats:sub>GT<\/jats:sub>\u200a=\u200a31.74\u200a\u00b1\u200a23.30%; Impact<jats:sub>HBT<\/jats:sub>\u200a=\u200a24.28\u200a\u00b1\u200a19.87%; \u0394<jats:sub>GT\u2212HBT<\/jats:sub>\u200a=\u200a7.46%; 95% confidence interval of \u0394<jats:sub>GT\u2212HBT<\/jats:sub>: 1.55%, infinite) and on patient management. The test\u2013retest reproducibility was better for the GT with urine accumulated from 0 to 5\u200ah: the intraclass correlation coefficient (ICC) was 0.5761, and the Kappa coefficient was 0.7548, indicative of substantial agreement between both tests. No serious adverse events were reported during the study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The GT has an impact on diagnostic thinking and patient management noninferior to that of the HBT, is reproducible and well tolerated. These results prove the clinical benefit of its use in the clinical practice (ClinicalTrials.gov identifier: NCT02636413).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013136","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T23:38:37Z","timestamp":1542152317000},"page":"e13136","source":"Crossref","is-referenced-by-count":10,"title":["Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test\u2013retest reproducibility of the Gaxilose test for hypolactasia diagnosis"],"prefix":"10.1097","volume":"97","author":[{"given":"Carmen","family":"Monsalve-Hernando","sequence":"first","affiliation":[{"name":"Venter Pharma S.L. Alcobendas, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crespo","sequence":"additional","affiliation":[{"name":"Gastroenterology Service, Hospital Universitario Ram\u00f3n y Cajal, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Ferreiro","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Virgen de la Victoria, M\u00e1laga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario de la Princesa, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Aldeguer","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Doctor Josep Trueta, Gerona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Opio","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario de Getafe, Getafe, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Luis","family":"Fern\u00e1ndez-Gil","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Cantabria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Clinical Analysis Laboratory, Hospital Universitario de Getafe, Getafe, Madrid, Spain.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Romero","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Virgen de la Victoria, M\u00e1laga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Lara","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Virgen de la Victoria, M\u00e1laga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilio","family":"Santander","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario de la Princesa, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyanira","family":"Torrealba","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario Doctor Josep Trueta, Gerona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Savescu","sequence":"additional","affiliation":[{"name":"Digestive System Service, Hospital Universitario de Getafe, Getafe, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Hermida","sequence":"additional","affiliation":[{"name":"Venter Pharma S.L. Alcobendas, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/2050640613484463","article-title":"Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment","volume":"1","author":"Misselwitz","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CEG.S32368","article-title":"Lactose intolerance: diagnosis, genetic, and clinical factors","volume":"5","author":"Mattar","year":"2012","journal-title":"Clin Exp Gastroenterol"},{"issue":"(Suppl. 1)","key":"R3-20230915","first-page":"S9","article-title":"Lactose intolerance","volume":"24","author":"Vandenplas","year":"2015","journal-title":"Asia Pac J Clin Nutr"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1373\/clinchem.2005.058446","article-title":"Noninvasive evaluation of intestinal lactase with 4-galactosylxylose: comparison with 3- and 2-galactosylxylose and optimization of the method in rats","volume":"52","author":"Hermida","year":"2006","journal-title":"Clin Chem"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1016\/j.bmc.2007.04.067","article-title":"Optimizing the enzymatic synthesis of beta-d-galactopyranosyl-d-xyloses for their use in the evaluation of lactase activity in vivo","volume":"15","author":"Hermida","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00005176-198605000-00006","article-title":"Mechanism of d-xylose transport in human small intestine","volume":"5","author":"Ohkohchi","year":"1986","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MCG.0b013e318272f507","article-title":"Phase I and phase IB clinical trials for the noninvasive evaluation of intestinal lactase with 4-galactosylxylose (gaxilose)","volume":"47","author":"Hermida","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MCG.0b013e318297fb10","article-title":"Noninvasive diagnosis of hypolactasia with 4-galactosylxylose (gaxilose): a multicentre, open-label, phase IIB-III nonrandomized trial","volume":"48","author":"Arag\u00f3n","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0272989X9101100203","article-title":"The efficacy of diagnostic imaging","volume":"11","author":"Fryback","year":"1991","journal-title":"Med Decis Making"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s003300050423","article-title":"The impact of medical imaging on the physician's diagnostic and therapeutic thinking","volume":"8","author":"Dixon","year":"1998","journal-title":"Eur Radiol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jclinepi.2007.03.015","article-title":"The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed","volume":"60","author":"Van den Bruel","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1177\/0272989X09336144","article-title":"Proposals for a phased evaluation of medical tests","volume":"29","author":"Lijmer","year":"2009","journal-title":"Med Decis Making"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/qjmed\/hcq082","article-title":"Lactose malabsorption and intolerance: a systematic review on the diagnostic value of gastrointestinal symptoms and self-reported milk intolerance","volume":"103","author":"Jellema","year":"2010","journal-title":"QJM"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jcla.21713","article-title":"Improvement and validation of d-xylose determination in urine and serum as a new tool for the noninvasive evaluation of lactase activity in humans","volume":"28","author":"Hermida","year":"2014","journal-title":"J Clin Lab Anal"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/thx.46.6.454","article-title":"Statistics in respiratory medicine. 2. Repeatability and method comparison","volume":"46","author":"Chinn","year":"1991","journal-title":"Thorax"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1148\/radiol.2203001429","article-title":"MR imaging of the wrist: effect on clinical diagnosis and patient care","volume":"220","author":"Hobby","year":"2001","journal-title":"Radiology"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2214\/AJR.14.12477","article-title":"Diagnostic yield of sonography in infants with suspected hip dysplasia: diagnostic thinking efficiency and therapeutic efficiency","volume":"204","author":"Ashby","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"(Suppl 1)","key":"R24-20230915","first-page":"1","article-title":"Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference","volume":"29","author":"Gasbarrini","year":"2009","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811160-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:11:29Z","timestamp":1694808689000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811160-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":21,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013136","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}